Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Beheshti, Y. Shafigh, A. Zangivand, Fatemeh Samiee-Rad, G. Hassanzadeh, N. Shafigh (2013)
Comparison of topical sucralfate and silver sulfadiazine cream in second degree burns in rats.Advances in clinical and experimental medicine : official organ Wroclaw Medical University, 22 4
Ida Marini, F. Vecchiet (2001)
Sucralfate: a help during oral management in patients with epidermolysis bullosa.Journal of periodontology, 72 5
Pierre Allain, Y. Mauras, N. Krari, J. Duchier, A. Cournot, J. Larcheveque (1990)
Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate.British journal of clinical pharmacology, 29 4
Marks In (1991)
Sucralfate--safety and side effects.Scandinavian Journal of Gastroenterology, 185
Pravin Gupta, P. Heda, Subhash Shrirao, S. Kalaskar (2011)
Topical Sucralfate Treatment of Anal Fistulotomy Wounds: A Randomized Placebo-Controlled TrialDiseases of the Colon & Rectum, 54
R. Burch, B. McMillan (1991)
Sucralfate induces proliferation of dermal fibroblasts and keratinocytes in culture and granulation tissue formation in full-thickness skin woundsAgents and Actions, 34
A. Hayashi, H. Lau, D. Gillis (1991)
Topical sucralfate: effective therapy for the management of resistant peristomal and perineal excoriation.Journal of pediatric surgery, 26 11
C. Durán-McKinster, Ana Rivera‐Franco, L. Tamayo, M. Orozco-Covarrubias, R. Ruíz-Maldonado (2000)
Bart Syndrome: The Congenital Localized Absence of Skin May Follow the Lines of Blaschko. Report of Six CasesPediatric Dermatology, 17
S. Szabó, D. Hollander (1989)
Pathways of gastrointestinal protection and repair: mechanisms of action of sucralfate.The American journal of medicine, 86 6A
I. Marks (1991)
Sucralfate--safety and side effects.Scandinavian journal of gastroenterology. Supplement, 185
Anjana Banati, Siti Chowdhury, Saswati Mazumder (2001)
Topical use of Sucralfate Cream in second and third degree burns.Burns : journal of the International Society for Burn Injuries, 27 5
M. Gonzalez (2013)
Evaluation and treatment of the newborn with epidermolysis bullosa.Seminars in perinatology, 37 1
Bart syndrome consists of aplasia cutis congenita (ACC) and dominant or recessive dystrophic epidermolysis bullosa (DEB), associated with skin fragility and nail dysplasia. ACC in DEB is thought to be caused by trauma, the most cited cause being in utero formation of bullae consequent to friction of the limbs. Epidermolysis bullosa (EB) refers to a hereditary mechanobullous disease following trauma, characterised by formation of blisters on the skin and mucous membranes. There are four categories of the disease, including epidermolysis bullosa simplex, junctional epidermolysis bullosa, dystrophic epidermolysis bullosa and Kindler syndrome. Infection, sepsis and death may occur as a consequence of generalised blistering with complication. We present the case of a newborn diagnosed with DEB and whose lesions became almost fully epithelialised after treatment with 10% topical sucralfate.
Journal of Wound Care – Mark Allen Group
Published: Nov 2, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.